Alhambra Investment Partners LLC Bristol Myers Squibb CO Transaction History

Alhambra Investment Partners LLC

$206 Million
Q3 2025

A detailed history of Alhambra Investment Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 7,227 shares of BMY stock, worth $313,579. This represents 0.16% of its overall portfolio holdings.

Number of Shares

7,227

Previous 8,797 17.85%

Holding current value

$313,579

Previous $407,000 20.15%

% of portfolio

0.16%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$43.31 - $48.98 $67,996 - $76,898	-1,570 Reduced 17.85%	7,227 $325,000
Q2 2025 Jul 15, 2025	BUY	$44.12 - $59.6 $81,577 - $110,200	1,849 Added 26.61%	8,797 $407,000
Q1 2025 Apr 15, 2025	SELL	$53.9 - $63.11 $15,145 - $17,733	-281 Reduced 3.89%	6,948 $423,000
Q4 2024 Jan 15, 2025	SELL	$51.92 - $59.94 $1,142 - $1,318	-22 Reduced 0.3%	7,229 $408,000
Q3 2024 Oct 15, 2024	SELL	$39.66 - $51.75 $61,948 - $80,833	-1,562 Reduced 17.72%	7,251 $375,000
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $369,293 - $486,183	-9,175 Reduced 51.01%	8,813 $366,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $342,337 - $388,144	-7,135 Reduced 28.4%	17,988 $975,000
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $18,810 - $22,445	-388 Reduced 1.52%	25,123 $1.29 Million
Q3 2023 Oct 17, 2023	BUY	$57.89 - $64.73 $23,213 - $25,956	401 Added 1.6%	25,511 $1.48 Million
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $6,052 - $6,720	95 Added 0.38%	25,110 $1.61 Million
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $49,348 - $55,972	751 Added 3.1%	25,015 $1.73 Million
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $58,550 - $69,331	-855 Reduced 3.4%	24,264 $0
Q3 2022 Oct 13, 2022	BUY	$0.13 - $76.84 $56 - $33,579	437 Added 1.77%	25,119 $1.79 Million
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $28,975 - $31,912	-399 Reduced 1.59%	24,682 $1.9 Million
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $54,778 - $65,684	-891 Reduced 3.43%	25,081 $1.83 Million
Q4 2021 Jan 21, 2022	BUY	$53.63 - $62.52 $120,613 - $140,607	2,249 Added 9.48%	25,972 $1.62 Million
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $70,648 - $82,756	1,194 Added 5.3%	23,723 $1.4 Million
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $37,455 - $40,789	605 Added 2.76%	22,529 $1.51 Million
Q1 2021 Apr 16, 2021	BUY	$59.34 - $66.74 $80,939 - $91,033	1,364 Added 6.63%	21,924 $1.38 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $21,075 - $23,881	365 Added 1.81%	20,560 $1.28 Million
Q3 2020 Nov 17, 2020	BUY	$57.43 - $63.64 $162,354 - $179,910	2,827 Added 16.28%	20,195 $1.22 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $13,595 - $15,894	-248 Reduced 1.41%	17,368 $1.02 Million
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $40,646 - $59,068	-876 Reduced 4.74%	17,616 $982,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $909,991 - $1.19 Million	18,492 New	18,492 $1.19 Million

Others Institutions Holding BMY

# of Institutions

2,672

Shares Held

1.63B

Call Options Held

22.4M

Put Options Held

25.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $92.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alhambra Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alhambra Investment Partners LLC with notifications on news.

Account

Alhambra Investment Partners LLC Bristol Myers Squibb CO Transaction History